To ascertain whether the anti-HCC effects of 4MOD treatment in vivo were associated with GADD45G upregulated expression, we used qRT-PCR and IHC assays to compare GADD45G mRNA and protein expression in xenograft tissues with or without 4MOD treatment. The gene discussed is GADD45G; the disease is hepatocellular carcinoma.